Coptis Chinensis affects the function of glioma cells through the down-regulation of phosphorylation of STAT3 by reducing HDAC3
Open Access
- 6 December 2017
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 17 (1) , 524
Abstract
Glioma remains the most common cause of brain cancer-related mortality. Glioma accounts for 50–60% of brain cancer. Due to their low toxicity and infrequent side effects, traditional herbs have been increasingly popular. Coptis Chinensis is commonly used in cancer treatment in combination with other Chinese Medicine herbs. However, little is known about its biological functions and mechanisms in glioma cells. In this study, the anti-glioma cell effect of Coptis Chinensis was determined using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) method, plate clone test, scratch tests, flow cytometry, western blotting and a glioma xenograft tumor model. The results showed that Coptis Chinensis significantly suppressed glioma cell proliferation, tumor formation, migration and tumor growth, and prolonged the survival time of glioma cell-bearing mice. The flow cytometry result showed that Coptis Chinensis induced cell cycle arrest and apoptosis in glioma cells. Western blotting showed that Coptis Chinensis down-regulated the Signal transducer and activator of transcription 3 (STAT3) phosphorylation levels and reduced the expression of Histone deacetylase 3 (HDAC3) and caspase 3. Coptis Chinensis can inhibit various aspects of glioma cell functions. This study provides favorable scientific evidence for the potential use of natural products such as Coptis Chinensis in the clinical treatment of patients with glioma.Keywords
Funding Information
- the Clinical Special Science Fund of Science and Technology of Jiangsu Province (BL2013006)
- Six-Talent Peak Fund of Jiangsu Province (WSW-063)
- 333 High-level Personnel Training Project Fund of Jiangsu Province (BRA2015051)
This publication has 28 references indexed in Scilit:
- Targeting of Histone Deacetylases to Reactivate Tumour Suppressor Genes and Its Therapeutic Potential in a Human Cervical Cancer Xenograft ModelPLOS ONE, 2013
- The quest for modernisation of traditional Chinese medicineBMC Complementary and Alternative Medicine, 2013
- A clinical review of treatment outcomes in glioblastoma multiforme—the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?British Journal of Radiology, 2012
- Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infectionBritish Journal of Radiology, 2012
- Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitorsClinical Epigenetics, 2012
- Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapyLeukemia, 2011
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancerCytokine & Growth Factor Reviews, 2010
- Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5BGenes & Development, 2008
- STAT3 as a central mediator of neoplastic cellular transformationCancer Letters, 2007
- STAT proteins: From normal control of cellular events to tumorigenesisJournal of Cellular Physiology, 2003